0

Journal Articles

in Cardiology
 81-100 of 1809 Articles
From the Centers for Disease Control and Prevention |  December 19, 2012 FREE
Newborn Screening for Critical Congenital Heart Disease: Potential Roles of Birth Defects Surveillance Programs—United States, 2010–2011
JAMA. 2012;308(23):2452-2454. doi:10.1001/jama.2012.64597.
Preliminary Communication |  December 12, 2012 FREE
Comparison of Allogeneic vs Autologous Bone Marrow–Derived Mesenchymal Stem Cells Delivered by Transendocardial Injection in Patients With Ischemic Cardiomyopathy:  The POSEIDON Randomized Trial
Joshua M. Hare, MD; Joel E. Fishman, MD, PhD; Gary Gerstenblith, MD; et al.
JAMA. 2012;308(22):2369-2379. doi:10.1001/jama.2012.25321.
INCLUDES: , Supplemental Content
Preliminary Communication |  December 12, 2012 FREE
Effect of the Use and Timing of Bone Marrow Mononuclear Cell Delivery on Left Ventricular Function After Acute Myocardial Infarction:  The TIME Randomized Trial
Jay H. Traverse, MD; Timothy D. Henry, MD; Carl J. Pepine, MD; et al.
JAMA. 2012;308(22):2380-2389. doi:10.1001/jama.2012.28726.
Editorial |  December 12, 2012
Mixed Results for Bone Marrow–Derived Cell Therapy for Ischemic Heart Disease
Eduardo Marbán, MD, PhD; Konstantinos Malliaras, MD
JAMA. 2012;308(22):2405-2406. doi:10.1001/jama.2012.64751.
Editorial |  November 28, 2012
Heart Failure Therapy:  What Should Clinicians Believe?
James C. Fang, MD
JAMA. 2012;308(20):2144-2146. doi:10.1001/jama.2012.45418.
Editorial |  November 28, 2012
Warfarin After Bioprosthetic Aortic Valve Implantation
Shamir R. Mehta, MD, MSc; Jeffrey I. Weitz, MD
JAMA. 2012;308(20):2147-2148. doi:10.1001/jama.2012.91476.
Medical News and Perspectives |  November 28, 2012
Consumer Group Asks FDA to Warn Patients About Hypertension Combination Therapy
Mike Mitka, MSJ
JAMA. 2012;308(20):2070-2071. doi:10.1001/jama.2012.25362.
Original Contribution |  November 28, 2012 FREE
Association Between Use of Renin-Angiotensin System Antagonists and Mortality in Patients With Heart Failure and Preserved Ejection Fraction
Lars H. Lund, MD, PhD; Lina Benson, MSc; Ulf Dahlström, MD, PhD; et al.
JAMA. 2012;308(20):2108-2117. doi:10.1001/jama.2012.14785.
INCLUDES: , Supplemental Content
Original Contribution |  November 28, 2012 FREE
Associations Between Aldosterone Antagonist Therapy and Risks of Mortality and Readmission Among Patients With Heart Failure and Reduced Ejection Fraction
Adrian F. Hernandez, MD, MHS; Xiaojuan Mi, PhD; Bradley G. Hammill, MS; et al.
JAMA. 2012;308(20):2097-2107. doi:10.1001/jama.2012.14795.
INCLUDES: , Supplemental Content
Original Contribution |  November 28, 2012 FREE
Association of Warfarin Therapy Duration After Bioprosthetic Aortic Valve Replacement With Risk of Mortality, Thromboembolic Complications, and Bleeding
Charlotte Mérie, MD; Lars Køber, MD, DMSc; Peter Skov Olsen, MD, DMSc; et al.
JAMA. 2012;308(20):2118-2125. doi:10.1001/jama.2012.54506.
INCLUDES: , Supplemental Content
Original Contribution |  November 21, 2012 FREE
Fish Oil and Postoperative Atrial Fibrillation:  The Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) Randomized Trial
Dariush Mozaffarian, MD, DrPH; Roberto Marchioli, MD; Alejandro Macchia, MD; et al.
JAMA. 2012;308(19):2001-2011. doi:10.1001/jama.2012.28733.
INCLUDES: , Supplemental Content
Original Contribution |  November 07, 2012 FREE
Platelet Function During Extended Prasugrel and Clopidogrel Therapy for Patients With ACS Treated Without Revascularization:  The TRILOGY ACS Platelet Function Substudy
Paul A. Gurbel, MD; David Erlinge, MD; E. Magnus Ohman, MB, ChB; et al.
JAMA. 2012;308(17):1785-1794. doi:10.1001/jama.2012.17312.
INCLUDES: , Supplemental Content
Editorial |  November 07, 2012 FREE
Measured Drug Effect and Cardiovascular Outcomes in Patients Receiving Platelet P2Y12 Receptor Antagonists:  Clarifying the Time and Place for Intensive Inhibition
Matthew J. Price, MD
JAMA. 2012;308(17):1806-1808. doi:10.1001/jama.2012.34011.
Editorial |  November 07, 2012
Time for a Creative Transformation of Epidemiology in the United States
Michael S. Lauer, MD
JAMA. 2012;308(17):1804-1805. doi:10.1001/jama.2012.14838.
Editorial |  November 07, 2012
Multivitamins in Prevention of Cardiovascular Disease
Eva M. Lonn, MD, MSc
JAMA. 2012;308(17):1802-1803. doi:10.1001/jama.2012.28259.
Editorial |  November 07, 2012
Viewing Cardiovascular Research Through the Eyes of Past, Present, and Future Generations
Eric D. Peterson, MD, MPH; J. Michael Gaziano, MD, MPH
JAMA. 2012;308(17):1809-1810. doi:10.1001/jama.2012.28743.
Lab Reports |  November 07, 2012
Inflammation and Atherosclerosis
Tracy Hampton, PhD
JAMA. 2012;308(17):1729. doi:10.1001/jama.2012.14656.
Research Letters |  November 07, 2012 FREE
Inclusion of Comparative Effectiveness Data in High-Risk Cardiovascular Device Studies at the Time of Premarket Approval
Connie E. Chen, MD; Sanket S. Dhruva, MD; Rita F. Redberg, MD, MSc
JAMA. 2012;308(17):1740-1742. doi:10.1001/jama.2012.14491.
Medical News and Perspectives |  November 07, 2012
New Basic Care Goals Seek to Rein In Global Rise in Cardiovascular Disease
Mike Mitka, MSJ
JAMA. 2012;308(17):1725-1726. doi:10.1001/jama.2012.13721.
Medical News and Perspectives |  November 07, 2012
New Anticoagulants Offer Options Beyond Warfarin to Reduce Stroke Risk
Mike Mitka, MSJ
JAMA. 2012;308(17):1727-1728. doi:10.1001/jama.2012.14623.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
RESEARCH LETTER  |  June 17, 2013
ω-3 Fatty Acid Supplements for Secondary Prevention of Cardiovascular Disease: From “No Proof of Effectiveness” to “Proof of No Effectiveness”
Andrea Messori, PharmD; Valeria Fadda, PharmD; Dario Maratea, PharmD; et al.
JAMA Internal Medicine
RESEARCH LETTER  |  June 17, 2013
Somatic Symptoms in Patients With Coronary Heart Disease: Prevalence, Risk Factors, and Quality of Life
Sebastian Kohlmann, MSc; Benjamin Gierk, MSc; Melanie Hümmelgen, MD; et al.
JAMA Ophthalmology
Ophthalmic Molecular Genetics  |  June 13, 2013
Distinct Ocular Expression in Infants and Children With Down Syndrome in Cairo, Egypt:  Myopia and Heart Disease
Hanan H. Afifi, MD, PhD; Amira A. Abdel Azeem, MD; Hala T. El-Bassyouni, MD, PhD; et al.
JAMA Dermatology
Off-Center Fold  |  June 12, 2013
Rapidly Enlarging Nodule on the Scalp—Quiz Case
Whitney Pollard, DO; James Pehoushek, MD, MPH
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems